Washington D.C.— Congressman Eliot L. Engel, a member of the House Diabetes Caucus and a top member on the House Energy and Commerce Committee’s Health Subcommittee, last week welcomed NY-16 advocates representing JDRF, an organization that supports type 1 diabetes research.
During the meeting, advocates discussed the importance of robust funding for the National Institutes of Health (NIH) and support for the Special Diabetes Program (SDP), which provides $150 million annually for type 1 diabetes research at NIH.
“I’m proud to represent such dedicated advocates, and to support critical programs like the SDP,” Engel said. “I was pleased to partner with 355 of my House colleagues from both sides of the aisle to call on Congressional leadership to maintain support for the Program, and I have long supported needed boosts to NIH funding. I will keep working to ensure that this critical research continues to bring needed cures to my constituents.”
“We are happy that Congressman Engel continues to support the SDP, which provides $150 million a year to the NIH for type 1 diabetes research,” said Rochelle Waldman, JDRF Board Member and Advocacy Team Chair for the Westchester/Fairfield/Hudson Valley Chapter. “For me personally, the research that the SDP allowed on the artificial pancreas is significant because my daughter is now using this device, which is making a difference in her life and the lives of so many others living with type 1 diabetes.”
Please note this press release was originally published on March 19, 2018 by Congressman Engel’s House of Representative’s office and posted to this website no sooner than 72 hours after initial publication.